I know one of them. I'd rather not say who though.
But they are travelling extremely well and couldn't be more happy with the results. They strongly recommend the treatment.
If this doesn't get through the FDA, it will be a very sad day for people who need the treatment.
- Forums
- ASX - By Stock
- PAR
- research reports and media
research reports and media, page-1955
-
-
- There are more pages in this discussion • 2,233 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
30.0¢ |
Change
-0.010(3.23%) |
Mkt cap ! $103.1M |
Open | High | Low | Value | Volume |
31.0¢ | 31.5¢ | 29.0¢ | $161.3K | 527.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 10756 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 62010 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1004 | 0.310 |
2 | 11588 | 0.305 |
2 | 10757 | 0.300 |
1 | 99965 | 0.295 |
5 | 87991 | 0.290 |
Price($) | Vol. | No. |
---|---|---|
0.285 | 12593 | 2 |
0.310 | 62010 | 3 |
0.320 | 45000 | 2 |
0.325 | 50366 | 4 |
0.330 | 125773 | 4 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online